Oracle
ORCL
Vale SA
VALE
Toll Brothers
TOL
4
D.R. Horton
DHI
5
Lennar Corp
LEN
US Stock MarketDetailed Quotes
HURA TuHURA Biosciences
- 3.970
- -0.130-3.17%
Close Apr 28 16:00 ET
- 3.970
- 0.0000.00%
Post 20:01 ET
173.41MMarket Cap-7.42P/E (TTM)
4.100High3.820Low105.44KVolume4.070Open4.100Pre Close416.45KTurnover0.58%Turnover RatioLossP/E (Static)43.68MShares14.59552wk High12.10P/B72.61MFloat Cap1.80052wk Low--Dividend TTM18.29MShs Float238000.000Historical High--Div YieldTTM6.83%Amplitude1.800Historical Low3.949Avg Price1Lot Size
TuHURA Biosciences Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q1)Sep 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | -23.24%-14.73M | 41.57%-1.89M | -18.60%-3.83M | -59.17%-11.95M | -74.58%-3.23M | -14.40%-7.51M | -1.85M | -6.56M |
| Net income from continuing operations | 26.04%-21.68M | 88.45%-2.16M | 74.12%-4.84M | -212.96%-29.32M | -778.02%-18.71M | -33.51%-9.37M | ---2.13M | ---7.02M |
| Operating gains losses | --313.77K | ---- | ---12.09K | ---- | ---- | 27.36%-294.07K | ---- | ---404.85K |
| Depreciation and amortization | -34.20%116.71K | -71.88%17K | -43.24%34.31K | -52.46%177.38K | -35.70%60.45K | -2.00%373.09K | --94.01K | --380.69K |
| Other non cash items | 24,849.73%1.28M | ---- | --17.38K | --5.12K | ---- | ---- | ---- | --629.29K |
| Change In working capital | 574.97%3.29M | 115.93%152K | 166.43%633.7K | -68.83%486.92K | -711.09%-953.95K | 421.26%1.56M | --156.11K | ---486.2K |
| -Change in prepaid assets | ---- | --156K | ---- | ---- | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | 979.19%3.64M | 99.67%-4K | 156.86%691.88K | -81.73%337.75K | -984.63%-1.22M | 493.01%1.85M | --137.55K | ---470.34K |
| -Change in other current assets | -340.20%-358.33K | ---- | -122.13%-58.19K | 152.07%149.18K | 1,316.83%262.88K | -3,455.35%-286.51K | --18.55K | --8.54K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---24.4K |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | -23.24%-14.73M | 41.57%-1.89M | -18.60%-3.83M | -59.17%-11.95M | -74.58%-3.23M | -14.40%-7.51M | ---1.85M | ---6.56M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -366.69%-6.05M | 0 | -3,474.93%-1.3M | -1.2M | -1,006.01%-36.28K | 0 | -3.28K | |
| Net PPE purchase and sale | 26.91%-57.91K | ---- | ---- | -118.39%-79.22K | ---- | -1,006.01%-36.28K | ---- | ---3.28K |
| Net business purchase and sale | -392.30%-5.99M | ---- | --0 | ---1.22M | ---1.2M | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -366.69%-6.05M | ---- | --0 | -3,474.93%-1.3M | ---1.2M | -1,006.01%-36.28K | --0 | ---3.28K |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 1,019.17%29.77M | 0 | 4.63M | -83.63%2.66M | 0 | 130.69%16.25M | -150K | 7.04M |
| Net issuance payments of debt | 963.99%28.57M | ---- | --4.9M | 867.14%2.69M | --0 | -219.02%-350K | ---150K | --294.07K |
| Net common stock issuance | 20,301.20%5M | ---- | ---- | ---24.75K | ---- | --0 | ---- | --5.6M |
| Net preferred stock issuance | ---- | ---- | ---- | ---- | ---- | 1,342.98%16.6M | ---- | --1.15M |
| Cash dividends paid | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --2.05M | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---5.84M | ---- | ---272.3K | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 1,019.17%29.77M | --0 | --4.63M | -83.63%2.66M | --0 | 130.69%16.25M | ---150K | --7.04M |
| Net cash flow | ||||||||
| Beginning cash position | -74.29%3.67M | -65.56%4.91M | -74.29%3.67M | 156.98%14.25M | 156.98%14.25M | 9.43%5.55M | --5.55M | --5.07M |
| Current changes in cash | 184.93%8.99M | 57.39%-1.89M | 117.97%796.46K | -221.60%-10.59M | -121.45%-4.43M | 1,721.77%8.71M | ---2M | --477.91K |
| End cash Position | 245.35%12.66M | -69.25%3.02M | -54.57%4.46M | -74.29%3.67M | 177.06%9.82M | 156.98%14.25M | --3.54M | --5.55M |
| Free cash flow | -22.91%-14.79M | 41.57%-1.89M | -18.60%-3.83M | -59.45%-12.03M | -74.58%-3.23M | -14.89%-7.54M | ---1.85M | ---6.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call